Study of Intravenous Administration of Allogeneic Adipose-Derived Mesenchymal Stem Cells for COVID-19-Induced Acute Respiratory Distress

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a Phase 2, randomized controlled, multicenter study to assess the safety and efficacy of COVI-MSC in the setting of current standard of care (SOC) treatments for COVID-19 infection in hospitalized subjects with ARD/ARDS.
Epistemonikos ID: a70b789c0f50765abdf5c2dfdd9c5b3db4ef69f3
First added on: Jan 28, 2021